Skip to content

Joseph Henry Arguinchona

NPI 1023696093ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Nashville, TN

Internal Medicine, Endocrinology, Diabetes & Metabolism in Nashville, Tennessee, licensed in TN, with an NPI issued in March 2021. Part D covered 94 prescriptions written in 2024, 82% of them generic. Novo Nordisk Inc reported $125.01 in payments in 2025, mostly food and beverage.

Overview

NPI1023696093
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 31, 2021
Last updated in NPPESAug 27, 2026
Certified by providerAug 27, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (TN)

Part D prescriptions in 2024

Prescriptions (claims)94 · 167 30-day fills
Patients39
Total drug cost$14,003
Generic share82% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$125.01 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$125.011

What the 2025 payments were for

  • Food and Beverage$125.01 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Nashville

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Tennessee →